Search

Kazuhiko Imakawa

age ~72

from Overland Park, KS

Also known as:
  • Kaz Imakawa
  • Ayako Imakawa
  • Atsuko Imakawa
  • Imakawa Kaz
Phone and address:
9213 W 117Th Ter, Overland Park, KS 66210
(913)6632331

Kazuhiko Imakawa Phones & Addresses

  • 9213 W 117Th Ter, Overland Park, KS 66210 • (913)6632331
  • Derby, KS
  • Shawnee Mission, KS
  • Columbia, MO
  • 9213 W 117Th Ter, Overland Park, KS 66210

Us Patents

  • Recombinant Production Of Human Interferon .Tau. Polypeptides And Nucleic Acids

    view source
  • US Patent:
    57053634, Jan 6, 1998
  • Filed:
    May 10, 1995
  • Appl. No.:
    8/438753
  • Inventors:
    Kazuhiko Imakawa - Derby KS
  • Assignee:
    The Women's Research Institute - Wichita KS
  • International Classification:
    C12N 1520
    C07K 14555
  • US Classification:
    435 6951
  • Abstract:
    The present invention describes the production of interferon-. tau. proteins and polypeptides derived therefrom. The antiviral and anticellular proliferation properties of these proteins and polypeptides are disclosed. One advantage of the proteins of the present invention is that they do not have cytotoxic side-effects when used to treat cells. Structure/function relationships for the interferon-. tau. protein are also described. In one aspect, the invention includes ovine interferon-. tau. In another aspect the invention includes multiple forms of human interferon-. tau.
  • Human Interferon .Tau. Proteins And Methods Of Use

    view source
  • US Patent:
    57388458, Apr 14, 1998
  • Filed:
    May 31, 1995
  • Appl. No.:
    8/443883
  • Inventors:
    Kazuhiko Imakawa - Derby KS
  • Assignee:
    The Women's Research Institute - Wichita KS
  • International Classification:
    C07K 14555
    A61K 3821
    C12N 1520
  • US Classification:
    424 854
  • Abstract:
    The present invention describes the production of interferon-. tau. proteins and polypeptides derived therefrom. The antiviral and anticellular proliferation properties of these proteins and polypeptides are disclosed. One advantage of the proteins of the present invention is that they do not have cytotoxic side-effects when used to treat cells. Structure/function relationships for the interferon-. tau. protein are also described. In one aspect, the invention includes ovine interferon-. tau. In another aspect the invention includes multiple forms of human interferon-. tau.

Get Report for Kazuhiko Imakawa from Overland Park, KS, age ~72
Control profile